MULTICENTER PHASE II STUDY OF SUNITINIB IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE UROTHELIUM (TCCU) WHO FAILED OR PROGRESSED AFTER FIRST LINE CHEMOTHERAPY (CT) FOR LOCALLY ADVANCED OR METASTATIC DISEASE. PRELIMINARY RESULTS
ANNALS OF ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要